Crinetics Pharmaceuticals
CRNX
$41.73
Share price
-7.00%
Change (1 day)
127.54%
Change (1 year)
Categories
EPS for Crinetics Pharmaceuticals (CRNX)
EPS in 2023 (TTM): -$3.41
According to Crinetics Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$3.41. In 2022 the company made an earnings per share (EPS) of -$3.16 a decrease over its 2021 EPS that were of -$2.80.
EPS history for Crinetics Pharmaceuticals from 2017 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$3.41 | 7.91% |
| 2022 | -$3.16 | 12.86% |
| 2021 | -$2.80 | 13.82% |
| 2020 | -$2.46 | 18.27% |
| 2019 | -$2.08 | 68.93% |
| 2018 | -$1.23 | 86.61% |
| 2017 | -$0.66 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -36.07% | 🇺🇸 USA |